Publisher
Springer Science and Business Media LLC
Subject
Dermatology,General Medicine
Reference6 articles.
1. Yu CL, Chou PY, Liang CS, et al. Isotretinoin exposure and risk of inflammatory bowel disease: a systematic review with meta-analysis and trial sequential analysis. Am J Clin Dermatol. 2023. https://doi.org/10.1007/s40257-023-00765-9.
2. Taylor MT, Margolis DJ, Kwatra SG, Barbieri JS. A propensity score matched cohort study identifying an association of acne, but not oral antibiotic or isotretinoin use, with risk of incident inflammatory bowel disease. J Am Acad Dermatol. 2023;S0190-9622(23)00083-X.
3. Sivaraman S, Rashtak S, Sivaraman S, Scherr R, Baron H, Stone C. Risk of inflammatory bowel disease from isotretinoin: a case-control study: 1711. Official journal of the American College of Gastroenterology | ACG [Internet]. 2014 [cited 2023 Mar 19];109:S506. https://journals.lww.com/ajg/Fulltext/2014/10002/Risk_of_Inflammatory_Bowel_Disease_From.1711.aspx.
4. Kridin K, Ludwig RJ. Isotretinoin and the risk of inflammatory bowel disease and irritable bowel syndrome—a large-scale global study. J Am Acad Dermatol. 2022;S0190–9622(22):03304–7.
5. Rashtak S, Khaleghi S, Pittelkow MR, Larson JJ, Lahr BD, Murray JA. Isotretinoin exposure and risk of inflammatory bowel disease. JAMA Dermatol. 2014;150:1322–6.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献